Biofrontera (B8F) Stock Statistics & Valuation Metrics

Biofrontera has a market cap or net worth of CHF13.32M. The enterprise value is $11.99.

Biofrontera has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Biofrontera’s return on equity (ROE) is -0.27 and return on invested capital (ROIC) is -6.58%.

The current PE Ratio of Biofrontera is ―. Biofrontera’s PEG ratio is 0.00.

In the last 12 months, Biofrontera had revenue of 13.19M and earned -3.96M in profits. Earnings per share was -0.65.

In the last 12 months, operating cash flow was 772.00K and capital expenditures 0.00, giving a free cash flow of 772.00K billion.

Biofrontera pays an annual dividend of ―, resulting in a dividend yield of ―

Biofrontera upcoming earnings date is Jun 3, 2026, TBA (Confirmed).

Biofrontera as a current ratio of 2.43, with Debt / Equity ratio of 127.25%

In the past 12 months, Biofrontera has paid 5.72M in taxes.

Biofrontera EV to EBITDA ratio is -21.16, with an EV/FCF ratio of -2.66.

Biofrontera has CHF3.08M in cash and marketable securities with CHF1.15M in debt, giving a net cash position of CHF1.93M billion.

Gross margin is 82.79%, with operating margin of -7.77%, and net profit margin of -30.06%.

The average price target for Biofrontera is ―, which is 11.43% higher than the current price. The consensus rating is ―